A user facility clinic manager reported a bloodline separation that occurred at the beginning of the patient¿s hemodialysis (hd) treatment.The separation was observed at the connection between the heparin line (which was leaking) and the arterial line.There was no damage noticed on the bloodlines.The patient¿s estimated blood loss (ebl) was approximately 5 ml, as most of their blood was returned.There was no patient injury, adverse events, or medical intervention required as a result of this event.The patient successfully completed treatment on the same machine with new supplies.The bloodlines are available for return to the manufacturer., harm, or adverse event was reported at intake.
|